Single-dose gene-editing therapy offers permanent solution to high cholesterol levels
New Scientist - 14-Nov-2023Early results show promise in eliminating the need for lifelong statins
Join the club for FREE to access the whole archive and other member benefits.
Physician scientist, human geneticist and professor at Harvard Medical School.
Sekar Kathiresan, a physician scientist and a human geneticist, is the Director of the Center for Genomic Medicine (CGM) at Massachusetts General Hospital (MGH), Ofer and Shelly Nemirovsky MGH Research Scholar, Director of the Cardiovascular Disease Initiative at the Broad institute, and a Professor of Medicine at Harvard Medical School.
Dr. Kathiresan leverages human genetics to understand the root causes of heart attack and to improve preventive cardiac care. Among his scientific contributions, Dr. Kathiresan has helped highlight new biological mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, and developed a genetic test for personalized heart attack prevention.
Visit website: http://www.kathiresanlab.org/about-sek/
See also: Harvard Medical School - Graduate medical school of Harvard University
Details last updated 25-Dec-2019
Early results show promise in eliminating the need for lifelong statins
Trials underway to test the safety, but affordability and acceptance of gene therapy are major concerns
Could prevent not only the complications but the heart disease per se in the future
Verve Therapeutics treatment targets PCSK9 gene